Sannappa Gowda Nirmala G, Shiragannavar Varsha D, Karunakara Shreyas H, Veeranna Ravindra P, Suvarna Deepak, Kumar Divya P, Santhekadur Prasanna K
Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
Xavier University School of Veterinary Medicine, Oranjestad, Aruba.
Biochem Biophys Rep. 2024 Jun 21;39:101754. doi: 10.1016/j.bbrep.2024.101754. eCollection 2024 Sep.
A sedentary lifestyle and physical inactivity leads to metabolic syndrome-associated comorbidities involving abdominal obesity, type 2 diabetes, hyperlipidaemia associated Cardiovascular Diseases (CVDs), and Metabolic dysfunction-associated fatty liver disease (MAFLD). In this study, we evaluated the novel hepato/cardio/adipo-protective role of Quercetin via Vitamin D Receptor, and elucidated its underlying mechanisms in reducing lipotoxicity, inflammation and fibrosis in high calorie diet induced metabolic syndrome. Male Swiss albino mice were fed with western diet and sugar water for multiple time intervals. -lipotoxicity, anti-inflammatory, and anti-fibrotic effect of Quercetin was assessed by Oil Red O, H&E and TMS staining at different time points. The lipid profile, mRNA expression of inflammatory markers (TNF- α, IL-1β, IL-6 and MCP-1), fibrotic markers (α-SMA, COL1A1, COL1A2), adiponectin, AdipoR2, and VDR expression levels were measured from RNA pools of adipose, liver and heart tissues. Also, lipid-lowering and anti-steatohepatitic effects of Quercetin was assessed using mouse 3T3-L1 adipocytes, rat H9c2 cardiac cells, and human HepG2 hepatocytes. Our results indicate that, western diet fed mice with Quercetin ameliorated lipid profile and lipotoxicity. Histopathological examination and gene expression data revealed that Quercetin reduced hepatic and cardiac inflammation and fibrosis-associated markers. Interestingly, Quercetin treatment increased the serum levels of adiponectin and mRNA expressions of AdipoR2 and VDR. experiments revealed the reduction in lipid accumulation of 3T3-L1 and fatty-acid-treated hepatic and cardiac cells following Quercetin treatment. These findings indicate that Quercetin exhibits a protective role on multiple organs through VDR activation and subsequent Adipo/AdipoR2 signaling in metabolic syndrome associated obesity, hepatic injury, and cardiac dysfunction.
久坐不动的生活方式和缺乏身体活动会导致与代谢综合征相关的合并症,包括腹部肥胖、2型糖尿病、与高脂血症相关的心血管疾病(CVDs)以及与代谢功能障碍相关的脂肪性肝病(MAFLD)。在本研究中,我们评估了槲皮素通过维生素D受体发挥的新型肝/心/脂肪保护作用,并阐明了其在减轻高热量饮食诱导的代谢综合征中的脂毒性、炎症和纤维化方面的潜在机制。雄性瑞士白化小鼠在多个时间间隔内喂食西式饮食和糖水。在不同时间点通过油红O、苏木精和伊红(H&E)以及天狼星红(TMS)染色评估槲皮素的抗脂毒性、抗炎和抗纤维化作用。从脂肪、肝脏和心脏组织的RNA样本中测量脂质谱、炎症标志物(肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6和单核细胞趋化蛋白-1)、纤维化标志物(α-平滑肌肌动蛋白、I型胶原蛋白α1链、I型胶原蛋白α2链)、脂联素、脂联素受体2(AdipoR2)和维生素D受体(VDR)的mRNA表达水平。此外,使用小鼠3T3-L1脂肪细胞、大鼠H9c2心肌细胞和人HepG2肝细胞评估槲皮素的降脂和抗脂肪性肝炎作用。我们的结果表明,喂食西式饮食并给予槲皮素的小鼠脂质谱和脂毒性得到改善。组织病理学检查和基因表达数据显示,槲皮素降低了肝脏和心脏炎症以及与纤维化相关的标志物。有趣的是,槲皮素治疗增加了血清脂联素水平以及AdipoR2和VDR的mRNA表达。实验显示,槲皮素治疗后3T3-L1以及脂肪酸处理的肝脏和心脏细胞中的脂质积累减少。这些发现表明,槲皮素在代谢综合征相关的肥胖、肝损伤和心脏功能障碍中通过激活VDR以及随后的脂联素/脂联素受体2信号传导对多个器官发挥保护作用。